FDA official logo
GSRS logo
PFDA official logo

HYALURONIDASE (HUMAN RECOMBINANT)

  • UNII: 743QUY4VD8
  • Preferred Substance Name: HYALURONIDASE (HUMAN RECOMBINANT)

  • 757971-58-7
  • 36-482-HYALURONOGLUCOSAMINIDASE PH20 (HUMAN) RECOMBINANT
  • CHEMOPHASE
  • CUMULASE
  • DARZALEX FASPRO COMPONENT HYALURONIDASE (HUMAN RECOMBINANT)
  • DARZALEX FASPRO TM COMPONENT HYALURONIDASE-FIHJ
  • ENHANZE
  • HERCEPTIN HYLECTA COMPONENT HYALURONIDASE (HUMAN RECOMBINANT)
  • HUMAN HYALURONIDASE
  • HYALURONIDASE (HUMAN RECOMBINANT) [USAN]
  • HYALURONIDASE (HUMAN RECOMBINANT) COMPONENT OF DARZALEX FASPRO
  • HYALURONIDASE (HUMAN RECOMBINANT) COMPONENT OF RITUXAN HYCELA
  • HYALURONIDASE (HUMAN)
  • HYALURONIDASE 1 (HUMAN SPERM SURFACE PROTEIN PH-20)-(1-447)PEPTIDE RECOMBINANT
  • HYALURONIDASE COMPONENT OF PHESGO
  • HYALURONIDASE FIHJ [WHO-DD]
  • HYALURONIDASE HUMAN RECOMBINANT
  • HYALURONIDASE HUMAN RECOMBINANT [MART.]
  • HYALURONIDASE OYSK [WHO-DD]
  • HYALURONIDASE RECOMBINANT HUMAN
  • HYALURONIDASE RECOMBINANT HUMAN [ORANGE BOOK]
  • HYALURONIDASE ZZXF [WHO-DD]
  • HYALURONIDASE, HUMAN
  • HYALURONIDASE, HUMAN RECOMBINANT
  • HYALURONIDASE-FIHJ
  • HYALURONIDASE-FIHJ COMPONENT OF DARZALEX FASPRO TM
  • HYALURONIDASE-OYSK
  • HYALURONIDASE-ZZXF
  • HYLENEX
  • HYLENEX RECOMBINANT
  • HYQVIA COMPONENT HYALURONIDASE RECOMBINANT HUMAN
  • LISPRO-PH20 COMPONENT RECOMBINANT HUMAN HYALURONIDASE
  • LISPRO-PH20 COMPONENT RHUPH20
  • PHESGO COMPONENT HYALURONIDASE
  • RHUPH20
  • RHUPH-20
  • RITUXAN HYCELA COMPONENT HYALURONIDASE (HUMAN RECOMBINANT)
  • SHP-671 COMPONENT RECOMBINANT HUMAN HYALURONIDASE
  • VORHYALURONIDASE ALFA
  • VORHYALURONIDASE ALFA [INN]
  • VORHYALURONIDASE ALFA [JAN]
  • VORHYALURONIDASE ALFA [WHO-DD]
  • VYVGART HYTRULO COMPONENT HYALURONIDASE (HUMAN RECOMBINANT)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.